RAR β Antibodies

Santa Cruz Biotechnology offers a broad range of RAR β Antibodies for investigating retinoic acid receptors in cellular processes. RAR β Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RAR β plays a crucial role in regulating gene expression in response to retinoic acid, influencing processes such as cell differentiation, proliferation, and apoptosis. The significance of RAR β in developmental biology and cancer research has established it as a key target for therapeutic interventions. Research focused on RAR β continues to reveal new insights into disease mechanisms and potential treatment approaches. Scientists worldwide rely on RAR β research to advance understanding of cellular regulation and development. Investigating RAR β expression patterns helps illuminate its role in both normal physiological processes and disease states. The extensive applications of RAR β monoclonal antibodies from Santa Cruz Biotechnology enable researchers to make meaningful contributions to scientific discovery and therapeutic development.